BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

967 related articles for article (PubMed ID: 34680470)

  • 1. Targeting Drug Chemo-Resistance in Cancer Using Natural Products.
    Talib WH; Alsayed AR; Barakat M; Abu-Taha MI; Mahmod AI
    Biomedicines; 2021 Sep; 9(10):. PubMed ID: 34680470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic effects of natural compounds and conventional chemotherapeutic agents: recent insights for the development of cancer treatment strategies.
    Castañeda AM; Meléndez CM; Uribe D; Pedroza-Díaz J
    Heliyon; 2022 Jun; 8(6):e09519. PubMed ID: 35669542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Collateral sensitivity of natural products in drug-resistant cancer cells.
    Efferth T; Saeed MEM; Kadioglu O; Seo EJ; Shirooie S; Mbaveng AT; Nabavi SM; Kuete V
    Biotechnol Adv; 2020; 38():107342. PubMed ID: 30708024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of Fourth Generation ABC Inhibitors from Natural Products: A Novel Approach to Overcome Cancer Multidrug Resistance.
    Karthikeyan S; Hoti SL
    Anticancer Agents Med Chem; 2015; 15(5):605-15. PubMed ID: 25584696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Research Progress in Reversal of Tumor Multi-drug Resistance via Natural Products.
    Guo Q; Cao H; Qi X; Li H; Ye P; Wang Z; Wang D; Sun M
    Anticancer Agents Med Chem; 2017 Nov; 17(11):1466-1476. PubMed ID: 29034843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticancer and chemopreventing natural products: some biochemical and therapeutic aspects.
    Karikas GA
    J BUON; 2010; 15(4):627-38. PubMed ID: 21229622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement of conventional anti-cancer drugs as new tools against multidrug resistant tumors.
    Dallavalle S; Dobričić V; Lazzarato L; Gazzano E; Machuqueiro M; Pajeva I; Tsakovska I; Zidar N; Fruttero R
    Drug Resist Updat; 2020 May; 50():100682. PubMed ID: 32087558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural Compounds as Anticancer Agents Targeting DNA Topoisomerases.
    Jain CK; Majumder HK; Roychoudhury S
    Curr Genomics; 2017 Feb; 18(1):75-92. PubMed ID: 28503091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overview of resistance to systemic therapy in patients with breast cancer.
    Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
    Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential of Natural-Based Anticancer Compounds for P-Glycoprotein Inhibition.
    Dinić J; Podolski-Renić A; Jeremić M; Pešić M
    Curr Pharm Des; 2018; 24(36):4334-4354. PubMed ID: 30648503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural products for combating multidrug resistance in cancer.
    Chen T; Xiao Z; Liu X; Wang T; Wang Y; Ye F; Su J; Yao X; Xiong L; Yang DH
    Pharmacol Res; 2024 Apr; 202():107099. PubMed ID: 38342327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A targeted nanoplatform co-delivering chemotherapeutic and antiangiogenic drugs as a tool to reverse multidrug resistance in breast cancer.
    Tian F; Dahmani FZ; Qiao J; Ni J; Xiong H; Liu T; Zhou J; Yao J
    Acta Biomater; 2018 Jul; 75():398-412. PubMed ID: 29874597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular approaches towards development of purified natural products and their structurally known derivatives as efficient anti-cancer drugs: current trends.
    Saha SK; Khuda-Bukhsh AR
    Eur J Pharmacol; 2013 Aug; 714(1-3):239-48. PubMed ID: 23819913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural products to prevent drug resistance in cancer chemotherapy: a review.
    Yuan R; Hou Y; Sun W; Yu J; Liu X; Niu Y; Lu JJ; Chen X
    Ann N Y Acad Sci; 2017 Aug; 1401(1):19-27. PubMed ID: 28891091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overcoming multidrug resistance in cancer: Recent progress in nanotechnology and new horizons.
    Majidinia M; Mirza-Aghazadeh-Attari M; Rahimi M; Mihanfar A; Karimian A; Safa A; Yousefi B
    IUBMB Life; 2020 May; 72(5):855-871. PubMed ID: 31913572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of oncogenic transcription factors by bioactive natural products in breast cancer.
    Hasanpourghadi M; Pandurangan AK; Mustafa MR
    Pharmacol Res; 2018 Feb; 128():376-388. PubMed ID: 28923544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ellagic Acid and Schisandrins: Natural Biaryl Polyphenols with Therapeutic Potential to Overcome Multidrug Resistance in Cancer.
    Yoganathan S; Alagaratnam A; Acharekar N; Kong J
    Cells; 2021 Feb; 10(2):. PubMed ID: 33669953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting Glucose Metabolism to Overcome Resistance to Anticancer Chemotherapy in Breast Cancer.
    Varghese E; Samuel SM; Líšková A; Samec M; Kubatka P; Büsselberg D
    Cancers (Basel); 2020 Aug; 12(8):. PubMed ID: 32806533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leaf Extracts from Dillenia philippinensis Rolfe Exhibit Cytotoxic Activity to both Drug-Sensitive and Multidrug-Resistant Cancer Cells.
    Dante RAS; Ferrer RJE; Jacinto SD
    Asian Pac J Cancer Prev; 2019 Nov; 20(11):3285-3290. PubMed ID: 31759350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural product-based therapeutics for the treatment of cancer stem cells: a patent review (2010 - 2013).
    Lee CH; Chen CY
    Expert Opin Ther Pat; 2015 Mar; ():. PubMed ID: 25740048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.